Down 57% in 2024, Is Recursion Pharmaceuticals a Buy on the Dip?
- Posted on October 15, 2024
- By Yahoo News
- 3 Views
Down 57% in 2024, Is Recursion Pharmaceuticals a Buy on the Dip?
This clinical-stage drugmaker's AI platform could speed up the development process, but initial results were disappointing.
